Selank

Human evidence can mean a controlled clinical study, an observational study, a safety or exposure report, or evidence from a particular finished formulation. Those are different kinds of information.

Limited human evidence. Some human evidence exists, but it is small, early, indirect, or limited to a particular formulation or population.

Preclinical means research in cells, tissues, or animals rather than in people. It can help researchers form a hypothesis, but it cannot establish a human benefit or a complete human safety profile.

Mouse studies report behavioral effects in anxiety and memory models. These findings cannot establish clinical effectiveness or human safety.[3]

Preclinical findings do not establish outcomes in people.

Risk information may describe the compound, a finished product, a route, a population, or product-quality concerns. The cited material does not replace a current product label or an individual professional assessment.

This section is about the United States only. Status applies to a product, formulation, route, population, and use—not to a name in the abstract. A status shown here is not a recommendation or a statement about another country.

• Source/status dateJul 22, 2026

  Research only

  Selank is not FDA approved. FDA lists Selank acetate among bulk substances that may present significant safety risks in compounding because available safety information is insufficient.

  Specific product form or route is not separately published in this status record.

  Open source context

The date above is the date attached to the published status record or source context. It is not necessarily the original approval date.

These prompts help organise a conversation with a qualified professional. They do not create a treatment recommendation, dose, or protocol.

• EvidenceWhich human evidence applies to the exact product, form, route, and use being discussed?
• What remains uncertainWhat is known, and what remains uncertain for this specific context?
• RisksWhich important warnings, common effects, and product-quality concerns should be discussed?
• U.S. statusWhat does the U.S. status cover, and what does it not cover?

Related means that the profiles share a topic, pathway, product context, or research question. It does not mean that they are equivalent.

• SemaxBoth are synthetic peptides with limited non-U.S. intranasal human literature and no U.S. approval.

PeptideGrid review date: Jul 22, 2026. Sources support the specific sections that cite them. Publication does not imply endorsement, equivalence, or individual suitability.

1. 1

   FDA GSRS record for Selank

   U.S. Food and Drug Administration Global Substance Registration System. Selank substance record.

   U.S. Food and Drug Administration · Accessed Jul 22, 2026 · Regulatory source

   Open source
2. 2

   Randomized comparative study of Selank in anxiety disorders

   Zozulia AA, et al. Efficacy and possible mechanisms of action of a new peptide anxiolytic Selank in the therapy of generalized anxiety disorders and neurasthenia. Zhurnal Nevrologii i Psikhiatrii. 2008;108(4):38-48.

   PubMed-indexed primary study · Published Jan 1, 2008 · Accessed Jul 22, 2026 · Clinical study

   Open source
3. 3

   Selank in a mouse anxiety model

   Kozlovskii II, et al. Selank and short-term memory in mice with different anxiety levels. Bulletin of Experimental Biology and Medicine. 2012;152(5):583-586.

   PubMed-indexed primary study · Published Jan 1, 2012 · Accessed Jul 22, 2026 · Preclinical study

   Open source
4. 4

   FDA: Certain bulk drug substances may present significant safety risks

   U.S. Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks.

   U.S. Food and Drug Administration · Published Jul 22, 2026 · Accessed Jul 22, 2026 · Regulatory source

   Open source